CBD Cosmetics vs Supplements: Choosing a Product Category in Europe
Choosing between CBD cosmetics vs supplements is not simply a formulation decision. It determines which European regulations apply, what documentation your brand needs, which claims you can make and how quickly your product may reach the market.
For brands planning to launch CBD products in Europe, three commercial routes appear most often:
- CBD cosmetics applied to the skin
- CBD food supplements intended for ingestion
- Non-ingestible CBD aroma or fragrance products
Each route has a different compliance framework. Cosmetics generally offer the most harmonised route across the EU, while ingestible CBD remains subject to the Novel Food authorisation system. Aroma products may avoid food and cosmetic rules only when their composition, labelling, instructions and marketing support a genuinely non-ingestible use.
This guide focuses primarily on the European Union. Great Britain is discussed separately because it has its own Novel Food process.
Key takeaways
- CBD cosmetics generally provide the clearest route for brands seeking a relatively fast EU launch.
- A cosmetic product still requires a Responsible Person, safety assessment, Product Information File and CPNP notification.
- CBD intended for ingestion generally requires Novel Food authorisation before being placed on the EU market.
- The EU’s 0.3% hemp threshold is not a universal THC limit for every finished CBD product.
- An aroma oil is not automatically exempt from regulation simply because the label says “not for consumption.”
- Product presentation, instructions, claims and reasonably foreseeable use must all support the selected category.
The three routes, briefly:
1. Cosmetic (topical) products:
CBD creams, balms, serums, massage oils and other products intended for external application generally fall under Regulation (EC) No 1223/2009 on cosmetic products.
Before placing a cosmetic on the EU market, the brand or its appointed Responsible Person must ensure that the product has undergone a safety assessment. It must also have a Cosmetic Product Safety Report, a Product Information File and a compliant label. The product must then be submitted through the Cosmetic Products Notification Portal.
CPNP submission is a notification, not a product approval. It does not remove the manufacturer’s or Responsible Person’s obligation to ensure that the formulation, ingredients, manufacturing process, claims and documentation comply with the Cosmetics Regulation.
Brands that do not want to develop a formulation from scratch can start with established white-label CBD products or an existing white-label CBD skincare range.
2. Food supplements (Novel Food):
CBD oils, capsules, gummies and other ingestible products generally fall within EU food law and the Novel Food framework.
A food considered novel may not be placed on the EU market until it has received authorisation and has been added to the Union list of authorised novel foods. As of 21 July 2026, CBD has not been added to that list as an authorised novel food ingredient. Applications have been submitted, but several procedures have also been terminated or remain unresolved.
This makes a CBD food supplement launch in Europe substantially more complex and uncertain than a cosmetic launch. National enforcement intensity may differ, but a less active local authority does not create EU-wide Novel Food authorisation.
Our detailed guide to CBD and Novel Food regulations explains the authorisation system and its implications for CBD businesses.
3. Aroma oils and room fragrance:
Products marketed exclusively for room fragrance, aroma or another genuine non-ingestible purpose do not automatically fall under food or cosmetic law.
However, “aroma oil” is not a formal EU approval category or a guaranteed regulatory exemption. The product may be subject to REACH, the Classification, Labelling and Packaging Regulation and the General Product Safety Regulation, depending on its composition, hazards, intended use and presentation.
A mixture classified as hazardous requires the applicable CLP labelling. A Safety Data Sheet is required only when the relevant REACH conditions are met; it is not automatically mandatory for every consumer fragrance product. General consumer-product safety and traceability obligations may also apply.
Labelling a product “not for consumption” will not necessarily protect the classification when the bottle design, serving instructions, dosage language, advertising or customer communication suggests oral use.
Comparison: which route fits which product
| Factor | Cosmetic | Food supplement | Aroma oil |
|---|---|---|---|
| Governing framework | EU Cosmetic Regulation 1223/2009 | Novel Food Regulation 2015/2283 | REACH/CLP |
| EU-wide approval status | Allowed with compliant formulation | Not yet authorised anywhere in the EU | Allowed as non-ingestible product |
| Required documentation | PIF, CPSR, CPNP notification | Novel Food dossier (EFSA) | Safety data sheet under CLP |
| THC handling | Flower/resin cannabis extracts restricted; leaf-derived or synthetic CBD permitted | Subject to THC impurity limits | Must avoid any ingestion framing |
| Typical time to market | Weeks | Years, application-dependent | Weeks |
| Enforcement risk | Low, if properly notified | Varies by country, and can shift quickly | Low, if marketing stays non-ingestible |
Enforcement isn't the same from one country to the next
What's written in the regulation and what actually happens on the ground are two different questions, and that gap is where most brands misjudge their risk. A category that one country barely enforces can get pulled from shelves overnight in the next.
Take France. In mid-May 2026, the food safety authority (DGAL), working alongside the DGCCRF, started actively enforcing the Novel Food rule against ingestible CBD; pulling unauthorised oils, gummies, and capsules from shops, pharmacies, and online listings across the country. Notably, cosmetic CBD products sat entirely outside that enforcement plan and weren't touched.
The UK is heading the other way, toward its first product-specific approvals. Back in August 2025, the Food Standards Agency opened a consultation on authorising three named CBD foods, a real step toward full Novel Food approval in Great Britain, rather than relying on the interim "Public List," which lets products already on sale before 13 February 2020 (and with an application submitted by 31 March 2021) stay on the market in the meantime. Most listed products are still waiting on evidence review, though, so this remains a slower and more restrictive path than cosmetics for now.
All of which is to say: check the country-specific status before you commit to a supplement launch, because it moves. Our guide to where CBD is legal in Europe covers member state positions in more detail, and we flag updates for clients as enforcement shifts.
The paperwork you'll need either way
Whichever category you launch under, expect buyers and regulators to ask for the same baseline documentation:
- Certificate of Analysis (COA) for every batch, confirming cannabinoid content and screening for contaminants
- Technical Data Sheet (TDS) covering specifications, storage, and shelf life
- Product Information File (PIF) and Cosmetic Product Safety Report (CPSR) for cosmetic products, prepared by a Responsible Person
- THC compliance data against the current 0.3% cultivation threshold under the EU Common Agricultural Policy
If you haven't worked with these documents before, our guide on how to read a COA walks through what each figure actually confirms, which is worth knowing before you sign off on any supplier.
So which route makes sense for your brand?
For most brands entering the market right now, cosmetics are the more practical starting point: a shorter time to market, compliance that holds EU-wide rather than country by country, and a manufacturing process we can support from formulation through CPNP notification. If you already have a supplement-focused audience and can stomach a multi-year regulatory timeline, the Novel Food route is still there, but it's a long-term bet, not a near-term launch plan. Aroma and fragrance products can sit alongside either route as a lower-risk addition, as long as the labelling never strays into ingestible territory.
Whether you're building on an existing formulation through our white label CBD products or developing something proprietary through private label CBD work, get the compliance category settled first. Everything downstream of it, whether packaging, marketing claims, even how you price the first batch, follows from that one decision.
FAQ
Is it legal to sell CBD in the EU right now?
It depends which category. CBD cosmetics are legal to sell across the EU under the Cosmetics Regulation, as long as products are properly notified and formulated from permitted material. CBD sold as an ingestible food supplement has no EU-wide authorisation yet, so its legal footing depends heavily on the member state and how actively that country happens to be enforcing Novel Food rules at the time.
Can I launch a CBD food supplement in Europe today?
Technically, in some member states with lighter enforcement, yes, but you'd be doing it without EU-wide Novel Food authorisation, and enforcement can change fast, as France showed in May 2026. We'd treat this as a higher-risk, longer-term route rather than something to build a launch plan around.
What's the practical difference between launching a CBD cosmetic versus a CBD supplement?
A cosmetic needs CPNP notification, a PIF, and a CPSR, and can usually reach market within weeks once the formulation and paperwork are done. A supplement needs a Novel Food dossier reviewed by EFSA, a process that's taken years without producing a single EU-wide approval so far, and its viability shifts from country to country in the meantime.
Does the THC limit change depending on which product category I choose?
The hemp source itself has to meet the EU's 0.3% THC cultivation threshold no matter the end product. Cosmetic formulations get an added layer on top of that: the SCCS's 2026 dermal safety opinion, which sets specific concentration limits for CBD and THC impurities in topical products.
Conclusion
If you want the fastest, most reliable way into the EU market today, it's the cosmetic route, backed by proper CPNP notification and documentation. Food supplements are still a longer-term, country-dependent bet until EU-wide Novel Food authorisation actually exists. Start by working out which category fits your timeline and target markets, then get in touch with our team about the formulation and compliance documents that route will need.
About us
At Essentia Pura, we specialize in manufacturing high-quality white label CBD and private label CBD products, helping businesses launch their own unique CBD brands. With cutting-edge hemp extraction methods and a commitment to compliance and quality, we support companies in the nutraceutical, pharmaceutical, and cosmetic industries. Whether you’re looking for ready-to-market formulations or custom solutions, we’re here to help you succeed in the growing CBD market.
You ask. We Answer.
This article reflects the regulatory environment as of July 2026 and is provided for informational purposes. It does not constitute legal advice. Regulations and enforcement can change quickly and vary by member state — confirm current requirements with a qualified legal advisor before launching.